James Scibetta serves as the Chief Executive Officer and Director of Maverick Therapeutics, leading the biotechnology enterprise through its specialized precision immunotherapy and T-cell-directed therapies. Working alongside experienced scientific and research executives, he has overseen corporate collaborations, clinical-stage developments, and operational strategies aimed at transforming targeted cancer treatment paradigms.